Arcus Biosciences Down Over 14%, on Track for Lowest Close Since March 2020 -- Data Talk

Dow Jones
19 Feb

Arcus Biosciences, Inc. $(RCUS)$ is currently at $11.18, down $1.92 or 14.66%

 

--Would be lowest close since March 23, 2020, when it closed at $10.50

--On pace for largest percent decrease since Dec. 20, 2022, when it fell 32.51%

--Snaps a three day winning streak

--Down 13.33% month-to-date

--Down 24.92% year-to-date

--Down 76.93% from its all-time closing high of $48.47 on Nov. 23, 2021

--Down 32.65% from 52 weeks ago (Feb. 20, 2024), when it closed at $16.60

--Down 44.6% from its 52-week closing high of $20.18 on Feb. 27, 2024

--Would be a new 52-week closing low

--Traded as low as $10.65; lowest intraday level since March 23, 2020, when it hit $9.86

--Down 18.67% at today's intraday low; largest intraday percent decrease since Dec. 20, 2022, when it fell as much as 33.96%

 

All data as of 3:22:33 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 18, 2025 15:25 ET (20:25 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10